Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Obstet Gynecol. 2009 Aug;114(2 Pt 1):354–364. doi: 10.1097/AOG.0b013e3181ae98c2

Figure 2.

Figure 2

Summation of randomized controlled trials reporting the effect of antenatal exposure of magnesium sulfate at less than 30 weeks on death or cerebral palsy (A), cerebral palsy (B), death (C), moderate-severe cerebral palsy (D), and death or moderate-severe cerebral palsy (E). This is a Forest plot with the meta-analysis (fixed effects Mantel-Haenszel model) of the treatment/exposure effect expressed as pooled relative risk (RR) with its 95% confidence interval (CI).